This review highlights the complex pathogenesis of viral myocarditis and summarizes evolving research on novel therapeutic targets for a condition that currently lacks definitive treatment.
Viral myocarditis still lacks definitive therapies; leaves open targeted interventions against cytopathic, apoptotic, and remodeling pathways for prospective trials.
Viral myocarditis is an elusive infection of the heart that is currently without an effective or definitive treatment. Viral myocarditis has a complex disease progression that can be divided into early, middle and late phases. Direct cytopathic injury, apoptosis, activation of the innate and adaptive immune system and cardiac remodeling have all been implicated in the pathogenesis of viral myocarditis. Novel treatment approaches are evolving at a rapid pace. The purpose of this review is to provide an update on current research focused on identifying potential treatment options for viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Miyamoto et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: